ask
us
4th International PPRI Conference titled 'Medicines access challenge – The value of pricing and reimbursement policies' October 2019 ♦♦♦ Policy Principles on Cross-country Collaborations on Medicines' Pricing and Access ♦♦♦ CMS considers foreign drug prices to hold down Medicare Part B spending

we can add great value to great companies

'Thank you very much; very much appreciated our collaboration'

- Director P&R International, major pharma company

'Thank you for your excellent collaboration on this project'

- VP Global P&R, Shire

'The tools developed for Global have generated a lot of interest from participating countries'

- Director, Market Access

'Thank you very much; very much appreciated our collaboration'

- Director P&R International,
major pharma company

'Extremely knowledgeable and a good fit for us'

- International Business Development executive

'Akceso’s output can be directly inserted into our regional and local pricing & access plan'

- Senior Manager Value & Access EU,
global biopharma

' Akceso also developed very practical tools beyond our original expectations, to support our own follow-up activities. '

- Director Market Access & Commercial Effectiveness,
Novo Nordisk International